🎉【Gate 3000万纪念】晒出我的Gate时刻,解锁限量好礼!
Gate用户突破3000万!这不仅是数字,更是我们共同的故事。
还记得第一次开通账号的激动,抢购成功的喜悦,或陪伴你的Gate周边吗?
📸 参与 #我的Gate时刻# ,在Gate广场晒出你的故事,一起见证下一个3000万!
✅ 参与方式:
1️⃣ 带话题 #我的Gate时刻# ,发布包含Gate元素的照片或视频
2️⃣ 搭配你的Gate故事、祝福或感言更佳
3️⃣ 分享至Twitter(X)可参与浏览量前10额外奖励
推特回链请填表单:https://www.gate.com/questionnaire/6872
🎁 独家奖励:
🏆 创意大奖(3名):Gate × F1红牛联名赛车模型一辆
👕 共创纪念奖(10名): 国际米兰同款球员卫衣
🥇 参与奖(50名):Gate 品牌抱枕
📣 分享奖(10名):Twitter前10浏览量,送Gate × 国米小夜灯!
*海外用户红牛联名赛车折合为 $200 合约体验券,国米同款球衣折合为 $50 合约体验券,国米小夜灯折合为 $30 合约体验券,品牌抱枕折合为 $20 合约体验券发放
🧠 创意提示:不限元素内容风格,晒图带有如Gate logo、Gate色彩、周边产品、GT图案、活动纪念品、活动现场图等均可参与!
活动截止于7月25日 24:00 UTC+8
3
BioSig commodity tokenization strategy
Key Points:* BioSig and Streamex merge to tokenize commodities on blockchain.
The initiative aims to introduce liquidity and transparency to the commodities market, impacting its $142 trillion value.
Funding and Institutional Backing in BioSig’s Commodity Shift
BioSig Technologies Inc., previously a medical technology company, has merged with Streamex to pivot towards blockchain tokenization of commodities. Led by CEO Henry McPhie, this endeavor includes securing up to $1.1 billion funding comprised of convertible bonds and equity facilities.
The merger seeks to integrate commodity trading onto blockchain platforms, notably enhancing liquidity and transparency. The initiative emphasizes gold-backed assets and targets a $142 trillion market landscape, marking a significant pivot for BioSig’s operations.
Blockchain Opportunity: BioSig Targets $142 Trillion Commodity Market
Did you know? BioSig’s move to tokenize commodities is reminiscent of earlier attempts like Pax Gold but is amplified by institutional backing and a $1.1 billion investment.
Solana (SOL) stands at $151.16 with a market cap of $80.96 billion, dominating 2.41% of the market. A trading volume of $3.77 billion reflects a 12.64% change. Over 90 days, Solana’s price rose by 41.89%, per CoinMarketCap data on July 8, 2025.
| | | --- | | DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. |